Juglans Regia Leaf

Dosage for Juglans Regia Leaf varies significantly based on the form and the condition being treated.

• For Topical Use (Skin Inflammation/Sweating): Healthcare providers typically recommend a decoction made from 2 to 3 grams of dried leaf per 100 mL of water. This is applied as a compress or soak for 15–30 minutes, two to three times daily.
• For Oral Supplementation: Standardized capsules may be dosed at 250 mg to 500 mg, taken once or twice daily.
• For Allergen Immunotherapy: Dosing is highly individualized and must be performed by an allergist. It typically involves a 'build-up' phase with increasing concentrations of the extract, followed by a maintenance dose.

The safety and efficacy of Juglans Regia Leaf in pediatric populations have not been extensively established in large-scale clinical trials.

• Topical Use: May be used in children over the age of 12 for minor skin irritations under medical supervision.
• Oral Use: Generally not recommended for children under 12 years of age due to the lack of safety data regarding juglone exposure.
• Allergy Testing: Pediatric use for allergy diagnosis must be conducted by a qualified pediatric allergist.

Renal Impairment

Patients with significant renal impairment (CrCl < 30 mL/min) should exercise caution. While Vitamin C is water-soluble, excessive intake can lead to the formation of calcium oxalate stones. Your doctor may recommend a lower dose or frequent monitoring of kidney function.

Hepatic Impairment

There are no specific dosage adjustments provided for hepatic impairment; however, because the polyphenols in Juglans Regia Leaf are metabolized in the liver, patients with cirrhosis or hepatitis should be monitored for signs of hepatotoxicity.

Elderly Patients

Geriatric patients often have reduced renal clearance and may be more susceptible to the constipating effects of high-tannin oral preparations. Dosing should start at the lower end of the therapeutic range.

• Oral Forms: Should be taken with a full glass of water. Taking the supplement with food may reduce the risk of gastrointestinal upset, although it may slightly delay the absorption of certain flavonoids.
• Topical Forms: Ensure the area is clean before applying a compress. Do not apply to open, bleeding, or severely infected wounds unless specifically directed by a physician.
• Storage: Store dried leaves and extracts in a cool, dry place away from direct sunlight. The active constituent juglone is sensitive to light and air, which can lead to oxidation and loss of potency.

If you miss a dose of Juglans Regia Leaf, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up, as this increases the risk of gastrointestinal irritation.

Signs of an oral overdose may include severe nausea, vomiting, abdominal pain, and constipation due to high tannin intake. In extreme cases, the juglone content could theoretically cause oxidative stress in the blood. If an overdose is suspected, contact your local poison control center or seek emergency medical attention immediately. Treatment is generally supportive, focusing on hydration and gastric protection.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or stop the medication without medical guidance, especially if using it for allergy desensitization.

When using Juglans Regia Leaf, the most frequently reported side effects are localized or gastrointestinal in nature.

• Topical Application: Mild skin irritation, redness, or a 'tanning' of the skin (a brownish discoloration) is common due to the reaction of tannins and juglone with skin proteins. This discoloration is temporary and usually fades after discontinuation.
• Oral Intake: Nausea and mild stomach discomfort are common, particularly if taken on an empty stomach. The high tannin content can cause a dry sensation in the mouth and throat.

• Gastrointestinal: Constipation is a known side effect of prolonged oral use, as tannins reduce intestinal motility and fluid secretion.
• Dermatological: Contact dermatitis or an itchy rash may occur in sensitive individuals.
• Systemic: Mild headaches or dizziness have been reported in a small percentage of patients taking oral extracts.

• Photosensitivity: Some patients may experience increased sensitivity to sunlight, leading to easier sunburn.
• Hepatotoxicity: While rare, there are theoretical concerns that very high doses of naphthoquinones could affect liver enzyme levels.
• Oxidative Stress: In individuals with G6PD deficiency, high doses of quinone-containing substances could theoretically trigger hemolysis (breakdown of red blood cells).

> Warning: Stop taking Juglans Regia Leaf and call your doctor immediately if you experience any of these serious symptoms.

• Anaphylaxis: Signs include swelling of the face, lips, or tongue; difficulty breathing; wheezing; and a rapid drop in blood pressure. This is a critical risk for individuals with known tree nut allergies.
• Severe Skin Reactions: Blistering, peeling, or a widespread painful rash (Stevens-Johnson Syndrome is not typically associated with this drug, but severe contact dermatitis can mimic early stages).
• Jaundice: Yellowing of the eyes or skin, dark urine, and right-sided abdominal pain, which may indicate liver distress.
• Hemolytic Anemia Symptoms: Extreme fatigue, pale skin, and shortness of breath.

Prolonged oral use of Juglans Regia Leaf (longer than 4–6 weeks) is generally discouraged. The high tannin concentration can interfere with the absorption of essential minerals, particularly iron, calcium, and zinc, potentially leading to nutritional deficiencies over time. Furthermore, chronic exposure to juglone has been studied in animal models for potential mutagenic effects, although human data is insufficient to establish a definitive long-term cancer risk.

At this time, there are no FDA black box warnings specifically for Juglans Regia Leaf. However, for the allergenic extract form, providers are cautioned regarding the risk of severe systemic allergic reactions during administration.

Report any unusual symptoms or persistent side effects to your healthcare provider. Monitoring of iron levels may be necessary if you are using this product long-term.

Juglans Regia Leaf is not a substitute for standard medical care. Patients should be aware that 'natural' does not always mean 'safe.' The active compounds in walnut leaves, particularly juglone and tannins, are pharmacologically active and can interact with various physiological processes. It is essential to use standardized products and follow medical advice strictly.

No FDA black box warnings for Juglans Regia Leaf. However, healthcare providers administering the allergenic extract form must be prepared to treat anaphylaxis and should observe patients for at least 30 minutes following an injection.

• Allergic Reactions / Anaphylaxis Risk: There is a significant risk of cross-reactivity for patients allergic to walnuts or other tree nuts. Even though the leaf is used, the presence of similar proteins can trigger a severe reaction.
• Gastrointestinal Disorders: Patients with a history of gastric ulcers, Crohn's disease, or ulcerative colitis should use Juglans Regia Leaf with extreme caution, as tannins can irritate the GI lining.
• G6PD Deficiency: Due to the quinone structure of juglone, individuals with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency should avoid high doses to prevent the risk of hemolytic anemia.
• Kidney Stones: Because it is classified as a Vitamin C [EPC], patients prone to oxalate kidney stones should monitor their total daily intake of ascorbic acid from all sources.

If your healthcare provider prescribes Juglans Regia Leaf for an extended period, the following may be monitored:

• Iron Levels: Ferritin and serum iron tests to ensure tannins are not causing malabsorption.
• Liver Function Tests (LFTs): Periodic checks of ALT, AST, and bilirubin if high-dose oral therapy is utilized.
• Skin Assessment: For patients using topical forms, regular inspection for signs of sensitization or contact dermatitis.

Juglans Regia Leaf is not known to cause sedation or cognitive impairment. It is generally considered safe to drive or operate machinery while using this substance, provided no allergic symptoms are present.

There is no direct contraindication between Juglans Regia Leaf and moderate alcohol consumption. However, alcohol can exacerbate the gastrointestinal irritation caused by tannins. It is advisable to limit alcohol if you experience stomach upset.

There is no known withdrawal syndrome associated with Juglans Regia Leaf. However, if used for its astringent properties to treat a condition like diarrhea or skin inflammation, stopping the medication abruptly may result in a return of symptoms.

> Important: Discuss all your medical conditions, especially nut allergies and kidney history, with your healthcare provider before starting Juglans Regia Leaf.

While few drugs are strictly contraindicated, Juglans Regia Leaf should not be used in combination with oral iron supplements at the same time of day. Tannins bind to non-heme iron in the gastrointestinal tract, forming insoluble complexes that prevent iron absorption. This can lead to the failure of iron deficiency anemia treatment.

• Anticoagulants and Antiplatelets (e.g., Warfarin, Clopidogrel): Juglone may have mild vitamin K-antagonistic or anti-aggregation effects. Combining these could theoretically increase the risk of bleeding. Close monitoring of INR is recommended.
• Hepatotoxic Drugs (e.g., Methotrexate, Amiodarone): Because of the potential for naphthoquinones to stress the liver, avoid combining high doses of Juglans Regia Leaf with other medications known to cause liver injury.

• Alkaloids (e.g., Atropine, Codeine): Tannins can precipitate alkaloids, reducing their absorption and efficacy.
• CYP3A4 Substrates: Preliminary studies suggest that walnut leaf extracts may inhibit CYP3A4 enzymes. This could increase the blood levels of drugs like simvastatin or certain calcium channel blockers, potentially increasing their side effects.
• Antidiabetic Medications: Juglans Regia Leaf may have a mild blood-glucose-lowering effect. Monitor blood sugar closely to avoid hypoglycemia.

• Dairy Products: The proteins in milk and cheese can bind to the tannins in Juglans Regia Leaf, neutralizing their astringent effect and potentially reducing the absorption of the leaf's flavonoids.
• High-Fiber Foods: May further slow the absorption of the active constituents.

• St. John's Wort: May compound the potential for photosensitivity.
• Other Tannin-Rich Herbs (e.g., Witch Hazel, Oak Bark): Using these together increases the risk of severe constipation and stomach irritation.
• Tea and Coffee: The additional tannins in these beverages can exacerbate the mineral-binding effects of Juglans Regia Leaf.

• Urinary Glucose Tests: High levels of Vitamin C (ascorbic acid) from the leaf can cause false-negative results in certain glucose oxidase-based urine tests.
• Fecal Occult Blood Test: Vitamin C can interfere with guaiac-based tests, potentially leading to false-negative results. Discontinue use 3 days prior to testing.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A complete medication review is necessary to prevent dangerous interactions.

Juglans Regia Leaf must NEVER be used in the following circumstances:

• Known Allergy to Walnuts or Tree Nuts: Due to the high risk of cross-reactive proteins that can trigger life-threatening anaphylaxis. This includes allergies to pecans, hickory nuts, and hazelnuts.
• Open Wounds or Large Areas of Broken Skin: Topical application to severely damaged skin can lead to systemic absorption of juglone, which may be toxic in high concentrations.
• Acute Gastritis or Peptic Ulcer Disease: The high tannin content will directly irritate the inflamed gastric mucosa, potentially worsening the condition or causing bleeding.

• Pregnancy and Lactation: Due to the lack of definitive safety data, use is only recommended if the potential benefit outweighs the risk to the fetus or infant.
• Constipation or Bowel Obstruction: The astringent nature of the tannins can severely worsen existing bowel motility issues.
• G6PD Deficiency: As mentioned, the quinone constituents pose a theoretical risk of red blood cell destruction.

Patients who are sensitive to other members of the Juglandaceae family (such as Butternut or Hickory) are likely to be cross-sensitive to Juglans Regia Leaf. Additionally, there is some evidence of cross-sensitivity with certain pollens (e.g., birch pollen) in the context of Oral Allergy Syndrome (OAS).

> Important: Your healthcare provider will evaluate your complete medical history, including any history of allergic reactions to food or environmental triggers, before prescribing Juglans Regia Leaf.

Juglans Regia Leaf is generally classified as Category C (by traditional standards). There are no adequate and well-controlled studies in pregnant women. Animal studies on juglone have suggested potential developmental toxicity at very high doses. It is recommended that pregnant women avoid oral Juglans Regia Leaf preparations. Topical use on small areas may be considered only under strict medical supervision during the second and third trimesters.

It is unknown whether the constituents of Juglans Regia Leaf, such as juglone or specific flavonoids, pass into human breast milk. Vitamin C does pass into milk, which is generally safe. However, the potential for tannins to cause constipation in the nursing infant or for juglone to cause oxidative stress remains a concern. Breastfeeding mothers should consult their pediatrician before use.

Juglans Regia Leaf is not FDA-approved for general use in children under 12. In the context of allergen extracts, it is used in children as young as 5 for immunotherapy, but only under the care of a specialist. There is a risk that high tannin intake could interfere with growth by inhibiting the absorption of essential minerals like iron and calcium.

Older adults are at an increased risk for side effects. Reduced kidney function can lead to higher systemic levels of metabolites. Furthermore, the constipating effect of tannins is more pronounced in the elderly, who may already have sluggish bowel function. Polypharmacy in this age group also increases the risk of drug-drug interactions, particularly with blood thinners and heart medications.

For patients with a GFR < 60 mL/min, oral use should be limited. The risk of secondary hyperoxaluria (excessive oxalate in the urine) from the Vitamin C component can lead to kidney stones or further renal damage. Monitoring of urinary oxalate levels may be required.

In patients with Child-Pugh Class B or C hepatic impairment, the metabolism of polyphenols is significantly slowed. This can lead to an accumulation of juglone, which may further stress the liver. Juglans Regia Leaf should be avoided in patients with active liver disease or unexplained elevations in transaminases.

> Important: Special populations require individualized medical assessment. Never start a new supplement or botanical treatment without consulting a specialist who understands your specific health profile.

Juglans Regia Leaf functions through a complex interplay of its primary constituents. The naphthoquinone juglone acts as a cytotoxic agent against pathogens by inducing oxidative stress and inhibiting the enzyme peptidyl-prolyl cis/trans isomerase (Pin1), which is involved in cell cycle regulation.

In the context of its Vitamin C [EPC] classification, it acts as a cofactor for the enzymes prolyl hydroxylase and lysyl hydroxylase, which are critical for the cross-linking of collagen fibers. This supports the structural integrity of the skin and blood vessels. The ellagitannins act as astringents by cross-linking with proteins (specifically proline-rich proteins) on tissue surfaces, forming a protective barrier that reduces exudation and inflammation.

The onset of the astringent effect is almost immediate upon topical contact. For oral Vitamin C effects, peak plasma concentrations are typically reached within 2–3 hours. The antimicrobial effects of juglone are dose-dependent, with minimum inhibitory concentrations (MICs) varying across bacterial and fungal species. Tolerance to the GI effects of tannins does not typically develop; rather, side effects may worsen with prolonged use.

| Parameter | Value |

|---|---|

| Bioavailability | 30-40% (for flavonoids); >80% (for Vitamin C at low doses) |

| Protein Binding | 70-90% (primarily albumin for juglone metabolites) |

| Half-life | 1.5 - 2 hours (Juglone); 10-20 hours (Vitamin C) |

| Tmax | 2 - 4 hours (Oral) |

| Metabolism | Hepatic (Glucuronidation, Sulfation); CYP3A4 inhibition potential |

| Excretion | Renal (80%), Fecal (20%) |

• Molecular Formula: C10H6O3 (Juglone)
• Molecular Weight: 174.15 g/mol (Juglone)
• Solubility: Sparingly soluble in water; highly soluble in alcohol and organic solvents.
• Structure: Juglone is a 1,4-naphthoquinone derivative with a hydroxyl group at the 5-position.

Juglans Regia Leaf is classified as a Botanical Drug and an Allergenic Extract. Within the EPC system, it is categorized as Vitamin C [EPC] and Non-Standardized Plant Allergenic Extract [EPC]. It shares therapeutic similarities with other tannin-rich botanicals like Quercus alba (White Oak) and Hamamelis virginiana (Witch Hazel).